Biogenerics and new technologies compete with 1st generation major protein products
The Business Intelligence firm La Merie S.L. reported that the US$ 32 bln market of major protein products with commencing patent expiry is endangered by generic products and by innovator solutions including engineered molecules and drug delivery solutions. Examples are the first biogeneric somatotropin now approved in the US and the European Union and Pfizer's inhaled insulin. Both examples mark the entry of new players into the lucrative human growth hormone (hGH) and insulin markets. More hGH biogeneric products including slow release formulations are approaching the US$ 2.3 bln market and lead to erosion and conversion from an innovator to a biogeneric market. Although estimated price cuts of 25 to 30% will be less than those for small molecule generics, cost pressure in the health care markets will support acceptance of biogeneric products. The US$ 11.2 bln erythropoietin market will face tough competition by consolidated biogeneric manufacturers. Numerous drug delivery solutions and protein engineering approaches are filling the pipelines with interferon, G-CSF, insulin and FSH products. These results and more were found in a search conducted by La Merie Business Intelligence.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
BGU researchers make breakthrough in the field of male fertility - Successfully generate mouse sperm in vitro
Nicole_Marthe_Le_Douarin
NetScientific appoints Dr François R. Martelet as Chief Executive Officer
First prion reduction product presented at the European Plasma Fractionation Association Conference

Unhealthy environment causes cardiovascular disease - Two-thirds of noncommunicable diseases caused by environmental factors
454 Life Sciences Initiates Collaborative Research Agreement with the Broad Institute - Collaboration Aims to Facilitate Disease-Related Genomic Studies
How a protein in your brain could protect against Alzheimer's disease - New research sets the stage for new therapeutic strategies for Alzheimer's disease

The relationship of proteins - Researchers have for the first time uncovered the proteome of 100 organisms from all domains of life
